Meyling H Cheok

18PUBLICATIONS
91CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Molecular medicinePharmacogenomicsTerahertz physics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 21, 2026
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia.

|Mar 19, 2026
Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistance.

Léa Barral, Nicolas Lespinasse, Camila Martin Cardozo

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Jul 15, 2025
Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity.

Romain Larrue, Sandy Fellah, Benjamin Hennart

|Jan 12, 2024
Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity.

Romain Larrue, Sandy Fellah, Benjamin Hennart

|May 19, 2023
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.

Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert

Pageof 3

Frequent Collaborators

7 joint publications

Nicolas Duployez

6 joint publications

Laurène Fenwarth

3 joint publications

Theresa Hahn

3 joint publications

Jude Fitzgibbon